Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System

IMPORTANCE: Using real-world data, the US Department of Veterans Affairs (VA) initiated a surveillance evaluation of edaravone after its approval for amyotrophic lateral sclerosis (ALS) in 2017. The use and safety of edaravone for patients with ALS in the VA health care system remain to be assessed....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Netw Open
Autori principali: Vu, Michelle, Tortorice, Kathryn, Zacher, Jennifer, Dong, Diane, Hur, Kwan, Zhang, Rongping, Good, Chester B., Glassman, Peter A., Cunningham, Francesca E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7536587/
https://ncbi.nlm.nih.gov/pubmed/33017028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.14645
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi